S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:GRNA

GreenLight Biosciences (GRNA) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free GRNA Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.30
▼
$0.30
50-Day Range
$0.30
▼
$0.30
52-Week Range
$0.18
▼
$5.90
Volume
732 shs
Average Volume
486,986 shs
Market Capitalization
$45.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
GRNA stock logo

About GreenLight Biosciences Stock (NASDAQ:GRNA)

FUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV.

GRNA Stock News Headlines

December 20, 2023 | bbc.com
Splashdown Quaywest gets green light for £3m upgrade
September 28, 2023 | bbc.com
Broadwalk Shopping Centre redevelopment given green light
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
September 19, 2023 | forbes.com
Greenlight Family Cash Card 2023 Review
July 24, 2023 | finanznachrichten.de
GreenLight Biosciences: GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023 | finance.yahoo.com
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 20, 2023 | finance.yahoo.com
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
June 13, 2023 | bizjournals.com
RNA company to lay off 96 employees in Lexington
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
June 5, 2023 | benzinga.com
GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight Biosciences
June 1, 2023 | bizjournals.com
RTP biotech went public a year ago. Now, it's being acquired
June 1, 2023 | bizjournals.com
The Petri Dish: GreenLight to go private; C4 licenses cancer drug for $392M
May 31, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating GreenLight Biosciences Holdings Buyout
May 30, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall Line
May 30, 2023 | msn.com
GreenLight Biosciences trades 36% higher on merger agreement with Fall Line Endurance Fund
May 30, 2023 | finance.yahoo.com
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 12, 2023 | msn.com
Recap: GreenLight Biosciences Q1 Earnings
May 12, 2023 | msn.com
GreenLight Biosciences GAAP EPS of -$0.19 beats by $0.08, revenue of $3.82M beats by $3.32M
May 11, 2023 | finance.yahoo.com
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
April 12, 2023 | finance.yahoo.com
GreenLight Biosciences Releases Inaugural Sustainability Report
April 1, 2023 | seekingalpha.com
GreenLight Biosciences draws private equity interest; up 10%
March 30, 2023 | finance.yahoo.com
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
March 28, 2023 | finance.yahoo.com
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
March 9, 2023 | finance.yahoo.com
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
March 7, 2023 | finance.yahoo.com
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
March 4, 2023 | bbc.co.uk
Greenlight Screenwriting Lab
March 1, 2023 | finance.yahoo.com
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
See More Headlines
Receive GRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRNA
CUSIP
N/A
CIK
1822691
Web
www.eiacorp.com
Phone
(760) 809-8079
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-167,050,000.00
Net Margins
-1,521.00%
Pretax Margin
-1,510.44%
Return on Equity
-374.26%
Return on Assets
-122.78%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
1.21
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$10.20 million
Price / Sales
4.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
151,681,000
Free Float
105,722,000
Market Cap
$45.43 million
Optionable
Not Optionable
Beta
1.44
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:GRNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media